Page last updated: 2024-08-21

quinazolines and dipyridamole

quinazolines has been researched along with dipyridamole in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (50.00)	18.7374
1990's	2 (14.29)	18.2507
2000's	4 (28.57)	29.6817
2010's	1 (7.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ferber, RH; Parrish, SL; Vigdahl, RL	1
Aherne, GW; Curtin, NJ; Harris, AL	1
Kawai, C; Murohara, Y; Takatsu, Y; Yui, Y	1
Curtin, NJ; Harris, AL; Newell, DR	1
Curtin, NJ; Harris, AL	1
Böhm, R	1
Clark, WF; Moriarity, TA; Reid, BD; Tevaarwerk, GJ	1
Bowman, KJ; Calvert, AH; Curtin, NJ; Golding, BT; Griffin, RJ; Huang, B; Loughlin, PJ; Newell, DR; Turner, RN	1
Danenberg, PV; Lehman, NL	1
Boyer, CR; Karjian, PL; Neuteboom, ST; Pegram, M; Wahl, GM	1
Karasawa, A; Katagiri, C; Kusaka, H; Mizutani, M; Nan-ya, K; Nishikawa, S; Noji, T; Sano, J	1
Azegami, Y; Kaneda, T; Nakajyo, S; Shimizu, K; Urakawa, N; Yamamoto, H	1
Buyniski, JP; Fleming, JS	1
Hasegawa, T; Higashino, H; Kataoka, M; Masaoka, Y; Matsui, R; Sakuma, S; Yamamoto, M; Yamashita, S	1

Reviews

1 review(s) available for quinazolines and dipyridamole

Article	Year
[Thrombocyte aggregation inhibitors--a new class of active substances. 2. Chemical and pharmacologic aspects of some agents]. Die Pharmazie, 1986, Volume: 41, Issue:2 Topics: Anti-Inflammatory Agents; Aspirin; Chemical Phenomena; Chemistry; Dipyridamole; Heterocyclic Compounds; Humans; Imidazoles; Phthalazines; Platelet Aggregation; Pyridazines; Pyridines; Pyrimidines; Quinazolines; Quinolines; Sulfinpyrazone	1986

Article

Year

[Thrombocyte aggregation inhibitors--a new class of active substances. 2. Chemical and pharmacologic aspects of some agents].

Die Pharmazie, 1986, Volume: 41, Issue:2

Topics: Anti-Inflammatory Agents; Aspirin; Chemical Phenomena; Chemistry; Dipyridamole; Heterocyclic Compounds; Humans; Imidazoles; Phthalazines; Platelet Aggregation; Pyridazines; Pyridines; Pyrimidines; Quinazolines; Quinolines; Sulfinpyrazone

1986

Other Studies

13 other study(ies) available for quinazolines and dipyridamole

Article	Year
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis. Thrombosis research, 1979, Volume: 16, Issue:1-2 Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Aspirin; Benzophenones; Carotid Arteries; Cattle; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Imidazoles; Indoles; Indomethacin; Lung Diseases, Obstructive; Male; Mice; Platelet Aggregation; Prostaglandins; Pyridines; Quinazolines; Rats; Sulfinpyrazone; Sulfonamides; Suloctidil; Thiophenes	1979
Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. Cancer research, 1991, May-01, Volume: 51, Issue:9 Topics: Cell Division; Cell Survival; Deoxyuracil Nucleotides; Dipyridamole; DNA Damage; Drug Synergism; Folic Acid; Humans; Lung Neoplasms; Quinazolines; Thymidine; Thymidylate Synthase; Time Factors; Tumor Cells, Cultured	1991
[The mode of action and clinical applications of phosphodiesterase inhibitors as anti-platelet drugs]. Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:4 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cilostazol; Coronary Disease; Coronary Thrombosis; Cyclic AMP; Dipyridamole; Fibrinolytic Agents; Humans; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinazolines; Tetrazoles	1989
Modulation of dipyridamole action by alpha 1 acid glycoprotein. Reduced potentiation of quinazoline antifolate (CB3717) cytotoxicity by dipyridamole. Biochemical pharmacology, 1989, Oct-01, Volume: 38, Issue:19 Topics: Biological Transport; Cell Division; Dipyridamole; Drug Synergism; Folic Acid; Folic Acid Antagonists; Humans; Nucleosides; Orosomucoid; Quinazolines; Thymidine; Tumor Cells, Cultured	1989
Potentiation of quinazoline antifolate (CB3717) toxicity by dipyridamole in human lung carcinoma, A549, cells. Biochemical pharmacology, 1988, Jun-01, Volume: 37, Issue:11 Topics: Carcinoma; Cell Survival; Dipyridamole; DNA; Drug Synergism; Folic Acid; Folic Acid Antagonists; Humans; Lung Neoplasms; Quinazolines; Thymidine; Thymidylate Synthase; Tumor Cells, Cultured	1988
Inhibitors of immune complex induced human platelet aggregation and release in plasma. Thrombosis research, 1982, Dec-01, Volume: 28, Issue:5 Topics: Antibodies; Antigen-Antibody Complex; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; DNA; Humans; Imidazoles; Indomethacin; Lupus Erythematosus, Systemic; Male; Platelet Aggregation; Quinazolines; Receptors, Fc; Sulfinpyrazone	1982
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding. British journal of cancer, 1999, Volume: 80, Issue:11 Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Division; Cell Survival; Dipyridamole; Drug Synergism; Enzyme Inhibitors; Folic Acid; Leukemia L1210; Mice; Molecular Structure; Orosomucoid; Protein Binding; Quinazolines; Structure-Activity Relationship; Thymidine; Thymidylate Synthase; Tumor Cells, Cultured	1999
Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy. Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:2 Topics: Antimetabolites, Antineoplastic; Colorectal Neoplasms; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Genes, p53; Humans; Phosphodiesterase Inhibitors; Quinazolines; Thiophenes; Thymidine; Tumor Cells, Cultured	2000
Nucleoside transport inhibitors, dipyridamole and p-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011. Anti-cancer drugs, 2002, Volume: 13, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Bromodeoxyuridine; Carrier Proteins; Cell Survival; Colonic Neoplasms; Dipyridamole; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Humans; Membrane Proteins; Nucleoside Transport Proteins; Quinazolines; Thioinosine; Thiophenes; Thymidylate Synthase; Tumor Cells, Cultured	2002
Adenosine uptake inhibition ameliorates cerulein-induced acute pancreatitis in mice. Pancreas, 2002, Volume: 25, Issue:4 Topics: Acute Disease; Adenosine; Amylases; Animals; Biological Transport; Ceruletide; Dipyridamole; Female; Lipase; Mice; Mice, Inbred BALB C; Models, Chemical; Pancreatitis; Piperazines; Pyrimidinones; Quinazolines; Theophylline	2002
Lack of cyclic nucleotide regulation of MBCQ-induced relaxation of rat ileal smooth muscle. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2003, Volume: 39, Issue:3 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Carbachol; Cholinergic Agonists; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dipyridamole; Ileum; Male; Muscle Relaxation; Muscle, Smooth; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Potassium; Purinones; Quinazolines; Rats; Rats, Wistar	2003
Enhanced platelet aggregability in dogs following myocardial infarction. Life sciences, 1977, Mar-01, Volume: 20, Issue:5 Topics: Animals; Blood Platelets; Carrier Proteins; Collagen; Coronary Vessels; Dipyridamole; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extracellular Matrix Proteins; Glycoproteins; Ligation; Myocardial Infarction; Platelet Aggregation; Quinazolines; Sulfinpyrazone	1977
In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs. Molecular pharmaceutics, 2014, Mar-03, Volume: 11, Issue:3 Topics: Administration, Oral; Albendazole; Animals; Antineoplastic Agents; Calorimetry, Differential Scanning; Cytochrome P-450 CYP3A Inhibitors; Dipyridamole; Drug Stability; Gefitinib; In Vitro Techniques; Intestinal Absorption; Ketoconazole; Male; Quinazolines; Rats; Rats, Sprague-Dawley; Solubility; Solvents; Tubulin Modulators; Vasodilator Agents	2014